Guardant Health, Inc. (GH)
NASDAQ: GH · Real-Time Price · USD
35.17
-0.35 (-0.99%)
Dec 3, 2024, 1:52 PM EST - Market open

Guardant Health Revenue

Guardant Health had revenue of $191.48M in the quarter ending September 30, 2024, with 33.87% growth. This brings the company's revenue in the last twelve months to $692.26M, up 29.20% year-over-year. In the year 2023, Guardant Health had annual revenue of $563.95M with 25.45% growth.

Revenue (ttm)
$692.26M
Revenue Growth
+29.20%
P/S Ratio
6.23
Revenue / Employee
$389,126
Employees
1,779
Market Cap
4.37B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023563.95M114.41M25.45%
Dec 31, 2022449.54M75.89M20.31%
Dec 31, 2021373.65M86.92M30.32%
Dec 31, 2020286.73M72.36M33.75%
Dec 31, 2019214.38M123.74M136.52%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Oscar Health 8.22B
Integer Holdings 1.71B
Alkermes 1.51B
Haemonetics 1.36B
Apellis Pharmaceuticals 715.22M
Ultragenyx Pharmaceutical 522.75M
ADMA Biologics 382.81M
Axsome Therapeutics 338.46M
Revenue Rankings